Indeed, repeated α-MSH administration reduced ventricular weight and cardiac fibrosis and improved LV systolic function in TAC-challenged mice, demonstrating that α-MSH protects against pathological cardiac remodeling. Here, STAMBP is linked to persistent truncus arteriosus.